share_log

Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $72 Price Target

Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $72 Price Target

古根海姆重申买入ANI Pharmicals,维持72美元的目标股价
Benzinga ·  2023/10/19 13:39

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $72 price target.

古根海姆分析师Vamil Divan重申ANI制药(纳斯达克:ANIP)买入,并维持72美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发